Quick Heal Technologies' Q2 FY25 Financial Results Show Mixed Performance, Investors Advised to Hold

Oct 18 2024 10:30 AM IST
share
Share Via
Quick Heal Technologies, a smallcap IT software company, has reported a flat performance in the quarter ending September 2024, with a significant increase in Profit After Tax (PAT) but a decrease in Profit Before Tax (PBT) and operating cash flow. Net sales have also declined, and non-operating income is high. Investors are advised to hold and monitor closely.

Quick Heal Technologies, a smallcap IT software company, has recently declared its financial results for the quarter ending September 2024. The company’s stock has been given a ‘Hold’ call by MarketsMOJO.


According to the financial report, Quick Heal Tech has shown a flat performance in the quarter, with a score of 4 out of 20, which is a decrease from the previous quarter. However, there are some positive aspects to the company’s financials.


One of the highlights is the significant growth in Profit After Tax (PAT) for the half-yearly period, which has increased by 5,742.86% year on year. This shows a very positive trend for the company’s profitability.


On the other hand, there are some areas that need improvement. The Profit Before Tax (PBT) less Other Income has fallen by -101.68% year on year, indicating a negative trend in the near term. Additionally, the company’s operating cash flow has been consistently decreasing over the last three years, which is a cause for concern.


The net sales for the quarter have also shown a negative growth of -6.21% year on year, indicating a decline in the company’s sales. Moreover, the non-operating income for the quarter is 102.56% of the PBT, which suggests that the company’s income from non-business activities is high and not sustainable in the long run.


Overall, Quick Heal Technologies has shown a mixed performance in the quarter ending September 2024. While there are some positive aspects, there are also areas that need improvement. Investors are advised to hold their position and monitor the company’s performance closely.


{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News